Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,173 | 53,382 | 26 | 2 | 0 |
| TOTAL | $50,711 | $53,663 | $26 | $2 | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,057 | 682 | 3 | N/A | N/A |
| Other Non-Current Assets | 1,054 | 1,053 | 10 | 0 | 0 |
| TOTAL | $2,111 | $1,735 | $13 | $N/A | $N/A |
| Total Assets | $52,822 | $55,398 | $38 | $2 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 567 | 87 | 212 | 3 | 2 |
| Accrued Expenses | 8,916 | 500 | N/A | N/A | N/A |
| TOTAL | $9,483 | $587 | $212 | $3 | $2 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 150 | 0 | 0 |
| TOTAL | $744 | $439 | $150 | $N/A | $N/A |
| Total Liabilities | $10,227 | $1,026 | $362 | $3 | $2 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,040 | 20,040 | 18,707 | 3,000 | 3,000 |
| Common Shares | 2 | 2 | 0 | 0 | 0 |
| Retained earnings | -22,066 | -10,240 | -393 | -72 | -69 |
| TOTAL | $42,595 | $54,372 | $-324 | $-2 | $-2 |
| Total Liabilities And Equity | $52,822 | $55,398 | $38 | $2 | $0 |